Dr. Kimchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Dr
Columbia, MO 65212Phone+1 843-882-8454Fax+1 573-884-6054
Education & Training
- University of ChicagoFellowship, Complex General Surgical Oncology, 2002 - 2005
- Detroit Medical Center/Wayne State UniversityResidency, Surgery, 1996 - 2002
- Pennsylvania State University College of MedicineClass of 1996
Certifications & Licensure
- MO State Medical License 2015 - 2026
- CT State Medical License 2024 - 2025
- SC State Medical License 2013 - 2025
- PA State Medical License 1996 - 2014
- IL State Medical License 2002 - 2005
- MI State Medical License 1996 - 2002
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Alpha Omega Alpha
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 1 citationsPulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors.Blake M Arciga, Dustin M Walters, Eric T Kimchi, Kevin F Staveley-O'Carroll, Guangfu Li
Cancer Letters. 2025-01-28 - 2 citationsPost-operative complications of cholecystectomy: what the radiologist needs to know.Irfan Amir Kazi, M Azfar Siddiqui, Nanda Deepa Thimmappa, Amr Abdelaziz, Ayman H Gaballah
Abdominal Radiology. 2025-01-01 - 2 citationsDriver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy.Olamide T Olaoba, Temitope I Adelusi, Ming Yang, Tessa Maidens, Eric T Kimchi
Cancers. 2024-05-09
Press Mentions
- UConn Health Minute: Gastroesophageal CancerNovember 1st, 2024
- Blood Biomarker May Help Verify CT-Captured Lung CancerJuly 13th, 2022
- Researchers Discover Effective Combination Immunotherapy for Liver CancerMay 18th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: